Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: A controlled, comparative, 12-month clinical trial
- 1 May 1989
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 160 (5) , 1269-1280
- https://doi.org/10.1016/s0002-9378(89)80012-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASEThe Lancet, 1988
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986
- Progestins and oral contraceptive-induced lipoprotein changes: A prospective studyContraception, 1986
- A randomized crossover comparison of two low-dose contraceptives: Effects on serum lipids and lipoproteinsAmerican Journal of Obstetrics and Gynecology, 1985
- Relative potency of progestins used in oral contraceptivesContraception, 1985
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- How LDL Receptors Influence Cholesterol and AtherosclerosisScientific American, 1984
- Family history of heart attack as an independent predictor of death due to cardiovascular disease.Circulation, 1984
- Risk of Myocardial Infarction in Relation to Current and Discontinued Use of Oral ContraceptivesNew England Journal of Medicine, 1981
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978